← All instruments
Dividend per share, restated for any split or bonus that came after — so a pre-split payout is comparable with a post-split one. FY25 is in progress: that bar shows what has been declared so far, not a full year.
Indo Us Biotech Limited
StockNSE: INDOUS· Face value ₹10
₹84.76
▲ 0.78%
Delayed · as of 29 Jul 2026
Dividend per share by financial year
| Financial year | Total dividend |
|---|---|
| FY22 | ₹0.10 |
| FY25 | ₹0.25 |
Dividend history
Source: NSE & BSE announcementsDownload CSV| Type | Amount (adjusted) | Ex-date | Record date | Payment date | FY | Confirmed by |
|---|---|---|---|---|---|---|
| INTERIM | ₹0.25 | 03 Dec 2024 | 03 Dec 2024 | — | FY25 | BSE + NSE |
| INTERIM | ₹0.10* | 28 Oct 2021 | 29 Oct 2021 | — | FY22 | BSE |
Amounts marked *were restated for a later split or bonus so they compare with today’s shares. Switch to “as filed” to see what was actually declared at the time — that is the figure on an old broker statement.
Other corporate actions
3 on record| Action | Ratio | Ex-date | Record date |
|---|---|---|---|
| Bonus issuehistory adjusted | 1:1 — 1 free share for every 1 held | 29 Aug 2023 | 29 Aug 2023 |
| Bonus issuehistory adjusted | 1:5 — 1 free share for every 5 held | 29 Nov 2021 | 30 Nov 2021 |
| Bonus issuehistory adjusted | 1:4 — 1 free share for every 4 held | 23 Apr 2019 | 24 Apr 2019 |
Splits and bonuses change the share count, so payouts declared before one are restated in the chart above to stay comparable. Buybacks, rights issues and mergers are listed for reference and do not affect those figures.